Blueprint Medicines, headquartered in Cambridge, MA, is a top-tier, publicly-traded (BPMC) company focused on discovering, developing and commercializing highly-selective kinase inhibitors for genomically defined diseases. The company has built a sophisticated genomics platform and one-of-a-kind annotated compound collection which is delivering a pipeline of novel therapies. In just four years, five programs have been established in genomically defined cancers and one program in the rare genetic disease space.
We are seeking an innovative, highly motivated senior biologist with deep experience in immunology and cancer biology to serve as a key leader in our effort to build our immuno-oncology drug discovery group. The selected individual will contribute immunology and cell and molecular biology expertise to small molecule drug discovery programs that lead to the identification of drug candidates for clinical development. This is a unique opportunity to join a clinical-stage company and contribute to our efforts as we become a fully commercialized biopharmaceutical organization.
All applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability or protected veteran status.
WHO WE ARE:
Blueprint Medicines’ mission is to dramatically improve the lives of patients with genomically defined diseases. Our singular focus is to use our deep understanding of the genetic blueprint of cancer and other diseases driven by the abnormal activation of kinases to craft highly selective medicines aimed at eradicating these diseases.
We don’t think in small steps. We think in giant leaps.
We are driven by the pursuit of new ideas, new innovations, and new ways of thinking.
We know that what each and every one of us does matters and that our success depends on our ability to work together. We believe we are at our best as a company when our employees are thriving and foster a culture that provides opportunities to grow and develop professionally, while also having fun.